Sargent Investment Group LLC Sells 500 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Sargent Investment Group LLC trimmed its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 13.6% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 3,190 shares of the company’s stock after selling 500 shares during the period. Sargent Investment Group LLC’s holdings in Henry Schein were worth $233,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. Cromwell Holdings LLC increased its stake in shares of Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after acquiring an additional 170 shares in the last quarter. Summit Securities Group LLC bought a new position in shares of Henry Schein during the second quarter valued at approximately $31,000. Beach Investment Counsel Inc. PA purchased a new position in shares of Henry Schein during the second quarter valued at approximately $37,000. Blue Trust Inc. boosted its position in shares of Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after purchasing an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC boosted its position in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after purchasing an additional 346 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analyst Ratings Changes

HSIC has been the subject of a number of recent research reports. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. JPMorgan Chase & Co. cut their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. Robert W. Baird decreased their target price on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Evercore ISI boosted their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $78.89.

Henry Schein Price Performance

Shares of HSIC opened at $66.54 on Friday. The firm has a market cap of $8.30 billion, a PE ratio of 27.38, a P/E/G ratio of 1.94 and a beta of 0.87. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a fifty day simple moving average of $70.30 and a two-hundred day simple moving average of $69.59.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.32 earnings per share. On average, equities analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current year.

Insider Buying and Selling

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.14% of the stock is currently owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.